Year: 2024
Type: article
Abstract: Introduction and Objective.Clinical use of the blue-green algae Spirulina has gained attention due to its potential health benefits.While some research suggests promising outcomes, the overall evidence is still limited, and further rigorous clinical trials are needed to validate its therapeutic efficacy and safety profile.Despite the need for more research, Spirulina continues to be explored as a potential adjunctive therapy in holistic health approaches and dietary supplementation. Review Methods.A search of the Pubmed, EMBASE, Cochrane Library, UpToDate databases was carried out using key words: 'spirulina' and 'spirulina supplementation' in order to find the latest publications.Brief description of the state of knowledge.Spirulina is considered a nutrient-dense food source, abundant in vitamins, minerals, amino acids, and antioxidants.Research indicates potential health benefits, including immune system support, anti-inflammatory effects, improved lipid profiles, and antioxidant properties.Studies have also investigated Spirulina's potential role in managing conditions such as obesity, diabetes, cardiovascular diseases, allergies, and cancer.While some studies show promising results, further research is needed to fully understand its mechanisms of action, optimal dosage, and long-term effects on human health.Summary.Despite limitations, numerous studies have explored the effectiveness and potential clinical uses of Spirulina in treating various diseases.Some randomized controlled trials and systematic reviews indicate that this alga could alleviate symptoms and potentially exhibit anti-cancer, antiviral, ant-inflammatory effects.
Language: English
Subfield: Aquatic Science
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W4400292575